NFE2L2 and myeloid sarcoma: Abnormally activated NRF2 pathway was also reported in MS patients (Dinkova-Kostova and Abramov, 2015; Draheim et al., 2016; Licht-Mayer et al., 2015; Rosito et al., 2020).